|
HY-P75932-10ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-P75932-5ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-P75932-50ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (Biotinylated, HEK293, His-Avi)
|
|
|
|
|
HY-P70687-10ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (HEK293, His)
|
|
|
|
|
HY-P70687-50ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (HEK293, His)
|
|
|
|
|
HY-P75933-10ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (HEK293, His, solution)
|
|
|
|
|
HY-P75933-5ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (HEK293, His, solution)
|
|
|
|
|
HY-P75933-50ug
|
MedChemexpress LLC
|
NCAM-1/CD56, Human (HEK293, His, solution)
|
|
|
|
|
HY-133512-10mg
|
MedChemexpress LLC
|
NCGC00249987 [CAS 1384864-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-133512-100mg
|
MedChemexpress LLC
|
NCGC00249987 [CAS 1384864-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-133512-25mg
|
MedChemexpress LLC
|
NCGC00249987 [CAS 1384864-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-133512-5mg
|
MedChemexpress LLC
|
NCGC00249987 [CAS 1384864-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-133512-50mg
|
MedChemexpress LLC
|
NCGC00249987 [CAS 1384864-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-W181102-100mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-W181102-50mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-W181102-1mL
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-100034-10mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-100mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-2mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-25mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-5mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-50mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-1mL
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-106961-10mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-106961-100mg
|
MedChemexpress LLC
|
ONO 1301 [CAS 176391-41-6]
|
|
Neuroscience-Neuromodulation
|
|
